pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

2,216 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1860Endpoints1444Fierce Biotech764BioSpace754BioPharma Dive546raps249onclive165fda recalls
therapy area
allOncology12884Rare Disease3329Immunology3020Cardiology2847Hematology2294Pulmonology2253Vaccines
  • FDA issues complete response letter rejecting Summit Therapeutics' lung cancer drug
    The U.S. Food and Drug Administration released a complete response letter that rejects Summit Therapeutics' lung cancer candidate, providing the agency’s detailed reasons for the decision. The age…
    STAT · 3h agoCRLNegative↗ source
  • Trump administration withdraws Heidi Overton’s FDA nomination amid Senate support concerns
    The Trump administration has pulled the nomination of Heidi Overton to become the U.S. Food and Drug Administration commissioner, saying she lacked sufficient backing to win Senate confirmation. T…
    STAT · 3h agoRegulatoryNeutral↗ source
← prev
page 1 of 89
next →
118
fda medwatch114
globenewswire health73
fda press61
1852
Psychiatry & CNS1230
Ophthalmology1131
Endocrinology & Metabolism806
Pain790
Nephrology783
  • Debate Over Medical School Structure Emerges as U.S. Loses Measles Elimination Status
    A discussion is unfolding about whether the traditional four‑year medical school model should be broken into separate components. The idea was voiced by a medical student who asked if every part of…
    STAT · 4h agoNegative↗ source
  • Loss of Senate Appropriations Chair Susan Collins could weaken scientists’ fight against new research oversight rule
    Senator Susan Collins, the Republican chair of the Senate Appropriations Committee, was defeated in her re‑election, ending her role as the most prominent GOP ally for science advocates. Scientist…
    STAT · 8h agoRegulatoryNegative↗ source
  • White House withdraws Heidi Overton's nomination to lead the FDA amid Senate Republican concerns
    The White House announced it is withdrawing its nominee, Heidi Overton, for FDA commissioner. Overton, a preventive care physician who previously served in the Trump administration, faced resistan…
    STAT · 17h agoRegulatoryNegative↗ source
  • Senate health panel blocks Trump pick for NSF over science integrity concerns
    The Senate health committee rejected the nomination of Jim O’Neill to lead the National Science Foundation after Chair Bill Cassidy voiced doubts about his commitment to scientific integrity. Cass…
    STAT · 2h agoRegulatoryNegative↗ source
  • Opinion calls for impeachment of Health Secretary Robert F. Kennedy Jr. over anti‑vaccine stance
    Professor Paul Knoepfler, a cell‑biology faculty member at UC Davis, argues that the post‑midterm political climate creates a window to remove Health and Human Services Secretary Robert F. Kennedy…
    STAT · 8h agoNegative↗ source
  • Opinion argues that traditional four-year medical schools may be outdated for pre-clerkship training
    Alex Serafini, a fourth‑year medical student at Icahn School of Medicine, contributes to a new First Opinion series that questions the structure of modern medical education. He notes that over the…
    STAT · 8h agoNeutral↗ source
  • FDA approves Roche's new breast cancer drug, poised to become its top-selling product
    The U.S. Food and Drug Administration has granted approval to a new breast cancer therapy developed by Roche. This clearance paves the way for the drug's market launch. Roche says the medication c…
    STAT · 1d agoApprovalPositive↗ source
  • Sellas' galinpepimut-S cuts death risk by 41% in Phase 3 AML trial
    Sellas Life Sciences announced that its experimental immunotherapy galinpepimut-S achieved a 41% reduction in risk of death for patients with advanced acute myeloid leukemia in a Phase 3 trial. Th…
    STAT · 1d agoPositive readoutPositive↗ source
  • Capsida proposes new monkey testing framework after fatal gene therapy trial for brain disease
    Researchers presented investigations into a patient death that occurred in a gene therapy trial for a brain disease, which had raised concerns in the field. While the exact cause of death was not…
    STAT · 1d agoNegative readoutNegative↗ source
  • HHS finalizes HIPAA privacy rule update to boost patient access to medical records
    The Department of Health and Human Services announced a final rule change to the HIPAA privacy regulations, marking the first major revision in nearly six years. The updates are designed to simpli…
    STAT · 22h agoRegulatoryPositive↗ source
  • GOP and MAHA leaders dispute FDA nominee Heidi Overton's vaping policy record
    Washington officials are locked in a public dispute over the nomination of Heidi Overton to lead the Food and Drug Administration. The controversy highlights growing divisions within the Republican…
    STAT · 23h agoRegulatoryNegative↗ source
  • Marrow Therapeutics raises $173 million to develop infusion therapy for sickle cell disease
    Marrow Therapeutics was announced on Tuesday by biotech entrepreneur Romesh Subramanian. The new company aims to create an infusion therapy for sickle cell disease that matches the efficacy of gene…
    STAT · 1d agoDealPositive↗ source
  • Flagship invests £100 million to launch AI-native biotech platform hub in the United Kingdom
    Flagship announced it will allocate £100 million to establish a new biotech creation outpost in the United Kingdom. The outpost will focus on building AI-native platform companies that aim to addr…
    STAT · 1d agoDealPositive↗ source
  • Flavored nicotine tablets launch, raising concerns over appeal to youth
    New flavored nicotine tablets that melt in the mouth have been introduced by tobacco companies in several markets. Products include Zyn Melts by Philip Morris International in the United Kingdom…
    STAT · 1d agoNegative↗ source
  • U.S. loses measles elimination status, sparking political criticism of vaccination response
    International health officials from the Pan American Health Organization announced that measles is no longer considered eliminated in the United States. The designation, first achieved in 2000, is…
    STAT · 1d agoRegulatoryNegative↗ source
  • Larbi Inc. recalls three lots of Yellow Dock Root over possible Salmonella contamination
    Larbi Inc. announced a recall of three lots of its Herb To Body Yellow Dock Root 4-oz product because it may be contaminated with Salmonella. The product was sold nationwide from January to Novemb…
    fda recalls · 18h agoCRLNegative↗ source
  • Democrats rally behind Medicare for More as Trump's chief of staff backs the plan
    Democrats are increasingly uniting around a new health care proposal called Medicare for More, which aims to broaden coverage beyond the existing system. The plan is drawing attention after the Wh…
    STAT · 1d agoNeutral↗ source
  • John Powers III named permanent director of NIH's National Institute of Allergy and Infectious Diseases
    NIH's National Institute of Allergy and Infectious Diseases (NIAID) has finally filled its top leadership vacancy that has persisted since 2025. The institute had been led in an acting capacity by…
    STAT · 1d agoNeutral↗ source
  • CMS releases new AI roadmap; highlights from HLTH conference
    The latest STAT Health Tech newsletter reports that the Centers for Medicare & Medicaid Services (CMS) has published a new artificial intelligence (AI) roadmap outlining its approach to AI integrat…
    STAT · 1d agoRegulatoryNeutral↗ source
  • RFK Jr. urges federal funding for faith-based addiction recovery centers, sparking expert concerns over medication access
    Health Secretary Robert F. Kennedy Jr. toured Sheepgate, a Christian addiction recovery center in Iowa, and said the model should receive federal funding. He highlighted the center as an example of…
    STAT · 1d agoRegulatoryNeutral↗ source
  • Zero-tolerance signs in hospitals may not curb staff violence, authors argue
    Hospitals across the United States now display signs telling patients and visitors that abusive language, disruptive conduct, or aggression will not be tolerated and may result in removal or police…
    STAT · 1d agoNegative↗ source
  • FDA approves Roche's Wilserdly for advanced HR-positive, HER2-negative breast cancer with ESR1 mutation
    The U.S. Food and Drug Administration has granted approval to Roche's new oral breast cancer therapy, Wilserdly (giredestrant). The decision clears the way for the drug's launch in the United State…
    STAT · 1d agoApprovalPositive↗ source
  • CG Oncology's bladder cancer immunotherapy cuts tumor recurrence risk by 68% in study
    CG Oncology reported that its bladder cancer immunotherapy, cretostimogene, achieved a 68% reduction in tumor recurrence compared with standard care. The treatment uses an engineered common cold v…
    STAT · 2d agoPositive readoutPositive↗ source